Yuta Tsujimoto

548 total citations
10 papers, 379 citations indexed

About

Yuta Tsujimoto is a scholar working on Genetics, Oncology and Surgery. According to data from OpenAlex, Yuta Tsujimoto has authored 10 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Yuta Tsujimoto's work include Glioma Diagnosis and Treatment (5 papers), Lymphatic System and Diseases (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Yuta Tsujimoto is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Lymphatic System and Diseases (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). Yuta Tsujimoto collaborates with scholars based in Japan. Yuta Tsujimoto's co-authors include Mika K. Kaneko, Yukinari Kato, Yoshihiko Sawa, Satoshi Ogasawara, Kaoru Goto, Masato Sugawara, Michiaki Takagi, Masashi Fukayama, Shinji Abe and Akiko Kunita and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cancer Science and Thrombosis Research.

In The Last Decade

Yuta Tsujimoto

10 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuta Tsujimoto Japan 10 195 120 112 106 85 10 379
Isabelle Quintin‐Roué France 13 138 0.7× 127 1.1× 123 1.1× 145 1.4× 130 1.5× 45 494
John W. Grant United Kingdom 10 175 0.9× 216 1.8× 81 0.7× 277 2.6× 127 1.5× 13 691
Ali Shahsafaei United States 13 155 0.8× 162 1.4× 142 1.3× 46 0.4× 106 1.2× 15 539
David Sumerauer Czechia 12 125 0.6× 34 0.3× 171 1.5× 119 1.1× 123 1.4× 48 443
Noraidah Masir Malaysia 12 163 0.8× 38 0.3× 90 0.8× 101 1.0× 51 0.6× 48 396
Marc Goldman United States 8 265 1.4× 97 0.8× 74 0.7× 62 0.6× 109 1.3× 11 469
Bradley Long United States 10 122 0.6× 34 0.3× 94 0.8× 87 0.8× 78 0.9× 12 380
Miguel A. Cruz Spain 11 250 1.3× 100 0.8× 277 2.5× 146 1.4× 91 1.1× 13 724
Carsten Schrader Germany 10 183 0.9× 67 0.6× 48 0.4× 76 0.7× 58 0.7× 15 355
Mirjam F. Mastik Netherlands 14 175 0.9× 119 1.0× 233 2.1× 40 0.4× 283 3.3× 28 656

Countries citing papers authored by Yuta Tsujimoto

Since Specialization
Citations

This map shows the geographic impact of Yuta Tsujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuta Tsujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuta Tsujimoto more than expected).

Fields of papers citing papers by Yuta Tsujimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuta Tsujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuta Tsujimoto. The network helps show where Yuta Tsujimoto may publish in the future.

Co-authorship network of co-authors of Yuta Tsujimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuta Tsujimoto. A scholar is included among the top collaborators of Yuta Tsujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuta Tsujimoto. Yuta Tsujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Oki, Hiroharu, Mika K. Kaneko, Satoshi Ogasawara, et al.. (2015). Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 34(3). 174–180. 31 indexed citations
2.
Kaneko, Mika K., Xing Liu, Hiroharu Oki, et al.. (2014). Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone. Cancer Science. 105(6). 744–748. 32 indexed citations
3.
Kaneko, Mika K., Yuta Tsujimoto, Yasukazu Hozumi, Kaoru Goto, & Yukinari Kato. (2013). Novel Monoclonal Antibodies GMab-r1 and LMab-1 Specifically Recognize IDH1-R132G and IDH1-R132L Mutations. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 32(3). 224–228. 10 indexed citations
4.
Ogasawara, Satoshi, Mika K. Kaneko, Yuta Tsujimoto, Xing Liu, & Yukinari Kato. (2013). Multi-Specific Monoclonal Antibody MsMab-2 Recognizes IDH1-R132L and IDH2-R172M Mutations. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 32(6). 377–381. 16 indexed citations
5.
Liu, Xing, Yukinari Kato, Mika K. Kaneko, et al.. (2013). Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi‐specific monoclonal antibody MsMab‐1. Cancer Medicine. 2(6). 803–814. 42 indexed citations
6.
Kaneko, Mika K., Yuta Tsujimoto, Hiroko Sasaki, et al.. (2013). Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations. Biochemical and Biophysical Research Communications. 432(1). 40–45. 24 indexed citations
7.
Takano, Shingo, Yukinari Kato, Tetsuya Yamamoto, et al.. (2012). Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors. Journal of Neuro-Oncology. 108(3). 361–373. 46 indexed citations
8.
Hatakeyama, Kinta, Mika K. Kaneko, Yukinari Kato, et al.. (2012). Podoplanin expression in advanced atherosclerotic lesions of human aortas. Thrombosis Research. 129(4). e70–e76. 44 indexed citations
9.
Kaneko, Mika K., Akiko Kunita, Shinji Abe, et al.. (2012). Chimeric anti‐podoplanin antibody suppresses tumor metastasis through neutralization and antibody‐dependent cellular cytotoxicity. Cancer Science. 103(11). 1913–1919. 70 indexed citations
10.
Tsujimoto, Yuta, et al.. (2012). Immunohistochemical Examination of Novel Rat Monoclonal Antibodies against Mouse and Human Podoplanin. ACTA HISTOCHEMICA ET CYTOCHEMICA. 45(4). 227–237. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Quintin‐Roué Breakdown of academic impact, for papers by John W. Grant Breakdown of academic impact, for papers by Ali Shahsafaei Breakdown of academic impact, for papers by David Sumerauer Breakdown of academic impact, for papers by Noraidah Masir Breakdown of academic impact, for papers by Marc Goldman Breakdown of academic impact, for papers by Bradley Long Breakdown of academic impact, for papers by Miguel A. Cruz Breakdown of academic impact, for papers by Carsten Schrader Breakdown of academic impact, for papers by Mirjam F. Mastik
Rankless by CCL
2026